Salwa Almefareh: Bringing Life-Changing Haemophilia Care to Patients Worldwide
Salwa Almefareh, Regulatory Affairs Specialist at Roche Middle East, Mohamed Naser Al-Hajery and Sons Ltd., shared a post on LinkedIn:
“True innovation in haemophilia A extends beyond scientific discovery, it is realized when innovation reaches the patients who need it most.
At Roche, we believe meaningful progress is driven by strong partnerships and a shared commitment to improving global health.
Our long-term support of the World Federation of Hemophilia WFH Humanitarian Aid Program reflects this commitment, helping expand access to care for people living with inherited bleeding disorders in low- and middle-income countries.
By working together across the healthcare ecosystem, we can help reduce disparities in care, strengthen health systems, and create a future where more people with haemophilia have the opportunity to receive timely, life-changing treatment.
Learn how collaboration continues to shape the future of haemophilia care.”
Stay updated with Hemostasis Today.
-
Sep 4, 2026, 22:03Maeve Crowley: Haemophilia Treatment Over the Decades and Hope for the Future
-
Sep 4, 2026, 22:01Lama Skieker: Understanding Thrombocytopenia in Malaria
-
Sep 4, 2026, 22:00Hiten Patel: How an IVC Filter Helps Prevent Pulmonary Embolism
-
Sep 4, 2026, 21:54Gianluca Costamagna: Investigating the Link Between Cancer and Acute Ischemic Stroke
-
Sep 4, 2026, 21:50Ben Creagh-Brown: PRAGUE-26 and HI-PEITHO Similar Benefits With Important Differences
-
Sep 4, 2026, 21:48Jin-Xiong She: Homocysteine beyond Heart Disease – The Methylation-Mobility Connection
-
Sep 4, 2026, 21:44Aravind Palraj: Anemia of Chronic Inflammation is Not Just “Iron Deficiency”
-
Sep 4, 2026, 21:41Chokri Ben Lamine: Fundamental HSCT Workshop for Hematology Fellows at HAAG 2026
-
Sep 4, 2026, 21:39Pierre Sabouret: A Good Surprise Our New Publication in Life Is Online